Press Releases & Statements

December 01, 2015

IPM Receives License from Janssen to Develop FDA-Approved HIV-1 Drug as Microbicide for HIV Prevention

Expands pipeline of next-generation sexual and reproductive health products for women SILVER SPRING, Md. (December 1, 2015) –  The International Partnership for Microbicides (IPM), a nonprofit... More »

November 03, 2015

IPM Initiates First Trial of Novel HIV Prevention Drug for Women

Study in Belgium evaluates safety and tolerability of novel ARV-based women’s health technologySILVER SPRING, Md. (November 3, 2015) – The nonprofit International Partnership for Microbicides (IPM)... More »

September 21, 2015

IPM Welcomes New Board Members

New members bring expertise in health policy, product development and reproductive health SILVER SPRING, Md. (September 21, 2015) — The International Partnership for Microbicides (IPM) today... More »

September 12, 2014

IPM Welcomes Executive Vice President, Global Product Access Lynn Bodarky and Chief Financial Officer Mike Goldrich

New EVP to lead product introduction plans as IPM prepares for dapivirine ring clinical trial results; CFO to lead financial management and business development SILVER SPRING, Md. (September 12,... More »

May 08, 2014

IPM Receives Worldwide Rights to HIV Prevention Medicine

Expanded public-private collaboration with Janssen Pharmaceutical Companies of Johnson & Johnson will speed development and global distribution of dapivirine-based HIV prevention tools for women... More »